Loading...
XLONNIOX
Market cap97mUSD
Oct 21, Last price  
44.17GBP
Name

Niox Group PLC

Chart & Performance

D1W1MN
XLON:NIOX chart
P/E
1,734.44
P/S
396.16
EPS
0.03
Div Yield, %
0.07%
Shrs. gr., 5y
3.75%
Rev. gr., 5y
0.44%
Revenues
47m
+27.30%
000015,918,12128,543,50262,632,31561,514,87045,836,37432,670,08937,715,22037,854,22036,800,00046,846,400
Net income
11m
0.00%
-14,513,000-15,498,000-19,981,000-35,100,000-73,547,618-169,654,673-134,057,505-149,138,537-63,985,459-45,792,8034,866,48016,100,00010,700,00010,700,000
CFO
16m
+33.88%
-13,986,000-18,325,000-17,881,000-36,900,000-77,821,929-69,196,370-76,565,638-51,071,352-32,721,342-32,670,0891,892,5198,223,92011,600,00015,530,599
Earnings
Mar 24, 2025

Profile

NIOX Group Plc, a diagnostics and management company, provides point-of-care fractional exhaled nitric oxide (FeNo) diagnosis and management products worldwide. Its products include NIOX VERO, a portable system for the non-invasive measurement of nitric oxide in human breath. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
URL
https://investors.niox.com/
IPO date
Mar 13, 2014
Employees
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
46,846
23.75%
36,800
-2.78%
37,854
0.37%
Cost of revenue
41,241
32,200
37,639
Unusual Expense (Income)
NOPBT
5,605
4,600
215
NOPBT Margin
11.97%
12.50%
0.57%
Operating Taxes
(6,874)
(5,400)
(4,354)
Tax Rate
NOPAT
12,480
10,000
4,569
Net income
10,700
-33.54%
10,700
-33.54%
16,100
230.83%
Dividends
(13,366)
(10,500)
Dividend yield
Proceeds from repurchase of equity
127
100
BB yield
Debt
Debt current
764
600
726
Long-term debt
1,136
1,600
884
Deferred revenue
(400)
Other long-term liabilities
136
484
Net debt
3,512
(17,700)
(26,086)
Cash flow
Cash from operating activities
15,531
11,600
8,224
CAPEX
(382)
(100)
(121)
Cash from investing activities
(382)
(300)
(121)
Cash from financing activities
(14,130)
(10,500)
(726)
FCF
6,314
11,320
(4,058)
Balance
Cash
25,333
19,900
23,462
Long term investments
(26,944)
4,233
Excess cash
18,060
25,803
Stockholders' equity
98,785
65,500
(674,240)
Invested Capital
107,278
66,840
773,700
ROIC
2.83%
2.38%
0.56%
ROCE
5.23%
5.42%
0.20%
EV
Common stock shares outstanding
449,278
449,278
442,998
Price
Market cap
EV
EBITDA
11,207
9,000
5,779
EV/EBITDA
Interest
100
200
363
Interest/NOPBT
1.78%
4.35%
168.47%